PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Supplementation with 1g or 3g of AHCC for 12 weeks significantly changed alanine aminotransferase (ALT) levels compared to placebo [PMID:25744424]
Patients receiving 6.0g of AHCC for 2 months showed significantly suppressed C-reactive protein (CRP) elevation, reduced albumin decline, and a lower frequency of taste disorders compared to controls [PMID:26847832]
AHCC was investigated for its ability to prolong survival and improve prognosis in patients with advanced hepatocellular carcinoma [PMID:16913187]
Daily intake of 3.0g for 4 weeks significantly increased the number of total circulating dendritic cells [PMID:18791928]
AHCC administration significantly decreased levels of HHV-6 in saliva and improved quality of life (QOL) scores during chemotherapy [PMID:24611562]
Safety & adverse effects
Dosage & administration
Evidence summary
PubMed sources
- 1.PMID: 25744424 (2014) — Effect of Active Hexose Correlated Compound (AHCC) in alcohol-induced liver enzyme elevation. · Journal of nutritional science and vitaminology
- 2.PMID: 18791928 (2008) — Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial. · Nutrition and cancer
- 3.PMID: 29111786 (2018) — Active Hexose Correlated Compound (AHCC) Inhibits the Proliferation of Ovarian Cancer Cells by Suppressing Signal Transducer and Activator of Transcription 3 (STAT3) Activation. · Nutrition and cancer
- 4.PMID: 16913187 (2006) — Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment. · Asian Pacific journal of allergy and immunology
- 5.PMID: 26847832